Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 07 May 2019 |
| Author/s |
author: Mansoor Raza Mirza Nicoletta Colombo Giovanni Scambia Ignace Vergote Christian Marth Bradley J. Monk |
| Publication date | May 7, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |